Health economics and policy challenges in global emerging markets /:
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York :
Nova Publishers,
[2016]
|
| Schriftenreihe: | Public health in the 21st century series.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9781634847209 1634847202 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBU-ocn946277667 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 160408s2016 nyu ob 001 0 eng | ||
| 010 | |a 2016017031 | ||
| 040 | |a DLC |b eng |e rda |e pn |c DLC |d N$T |d YDXCP |d OCLCF |d EBLCP |d YDX |d AGLDB |d AU@ |d STF |d DLC |d OCLCO |d OCLCA |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO | ||
| 019 | |a 959536277 |a 959650782 | ||
| 020 | |a 9781634847209 |q (ebook) | ||
| 020 | |a 1634847202 | ||
| 020 | |z 9781634847087 |q (hardcover) | ||
| 020 | |z 1634847083 | ||
| 035 | |a (OCoLC)946277667 |z (OCoLC)959536277 |z (OCoLC)959650782 | ||
| 042 | |a pcc | ||
| 050 | 1 | 0 | |a RA410.5 |
| 060 | 4 | |a W 74 | |
| 072 | 7 | |a BUS |x 070000 |2 bisacsh | |
| 082 | 7 | |a 338.4/73621 |2 23 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Health economics and policy challenges in global emerging markets / |c Mihajlo Jakovljevic, MD, PHD, editor. |
| 264 | 1 | |a New York : |b Nova Publishers, |c [2016] | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Public health in the 21st century | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record and CIP data provided by publisher. | |
| 505 | 0 | |a HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 BRICS VS. N-11: POPULATION AGING AND HEALTH EXPENDITURES IN GLOBAL EMERGING MARKETS- HISTORICALS RECORDS AND UN FORECASTS 1975 -- 2025 ; ABSTRACT ; INTRODUCTION ; METHODS ; Data Sources; Data Analysis ; RESULTS ; DISCUSSION; STUDY LIMITATIONS ; CONCLUSION; ACKNOWLEDGMENTS ; REFERENCES. | |
| 505 | 8 | |a Chapter 2 WHAT CAN EMERGING MARKETS LEARN FROM A PUBLIC LONG-TERM CARE INSURANCE SYSTEM FROM A MATURE COUNTRY: EXPERIMENTAL STUDY? ABSTRACT ; INTRODUCTION ; METHODS; The Public Long-Term Care Insurance (LTCI) System in Japan ; Introduction of the LTCI System in Japan ; A Structural Model to Measure the Effect of Public Long-Term Care Insurance System on Welfare Changes in Households ; EMPIRICAL AND EXPERIMENTAL RESULTS AND ANALYSIS ; The Data Set ; The Robust OLS Results for the Pooled Cross Section Data Set ; The Robust OLS Results for the Two-Year Data Set (2000 and 2003) in Table 6. | |
| 505 | 8 | |a Calculation of Values of Risk, Loss Variance and Absolute Risk Aversion (ARA) Discussion about the Factor of Economic Recession ; SUMMARY AND CONCLUSION; REFERENCES ; Chapter 3 INCORPORATION OF MULTI-CRITERIA DECISION ANALYSIS INTO HEALTH TECHNOLOGY ASSESSMENT: EXPERIENCES AND CHALLENGES FROM BULGARIA ; ABSTRACT; INTRODUCTION ; METHODS ; Key Theoretical Issues of MCDA ; Selecting Criteria ; Generic and Case-Specific MCDA Models ; International Experience on Combining HTA and MCDA ; From a Single ICER Measure to a Broader Set of Criteria ; Practical Lessons from Real-World MCDA Models. | |
| 505 | 8 | |a Incorporation of MCDA into HTA in BulgariaThe Bulgarian Experience in Incorporating MCDA into HTA ; Weaknesses of the Bulgarian HTA Process ; Weaknesses of the Bulgarian MCDA Framework ; CONCLUSION ; REFERENCES ; Chapter 4 WILLINGNESS-TO-PAY FOR A NEW PHARMACEUTICAL: IS IT WORTH THE MONEY? WHOSE MONEY? ; ABSTRACT ; 1. INTRODUCTION ; 2. LITERATURE REVIEW ; Cost-Effectiveness Studies ; WTP Studies ; 3. THE EXPERIMENT ; Sample and Interview Strategy ; Questionnaire ; Attributes ; Pretest and Design ; 4. EX-ANTE VS. EX-POST WILLINGNESS TO PAY ; 5. HYPOTHESES ; 6. DATA: DESCRIPTIVE STATISTICS. | |
| 505 | 8 | |a 7. EMPIRICAL RESULTS7.1. Willingness-to-Pay Values ; 7.2. Willingness-to-Pay Values Across Subgroups ; CONCLUSION ; DISCLAIMER; REFERENCES ; Chapter 5 THE HEALTH ECONOMICS OF NON-EPILEPTIC ATTACK DISORDER IN IRELAND ; ABSTRACT ; INTRODUCTION ; Incidence and Prevalence of NEAD in Ireland ; Estimation of Costs; Cost-of-Illness Analysis ; Measurement of Costs ; Incidence of NEAD in Ireland ; Using Iceland Figures (Sigurdardottir and Olafsson, 1998) ; Using Hamilton County, Ohio, Figures (Szflarski et al. 2000) ; Economic Cost of NEAD in Ireland ; Prevalence Based Cost-of-Illness. | |
| 650 | 0 | |a Medical economics. |0 http://id.loc.gov/authorities/subjects/sh85082915 | |
| 650 | 0 | |a Medical policy. |0 http://id.loc.gov/authorities/subjects/sh85083002 | |
| 650 | 0 | |a World health. |0 http://id.loc.gov/authorities/subjects/sh85148199 | |
| 650 | 2 | |a Global Health |0 https://id.nlm.nih.gov/mesh/D014943 | |
| 650 | 2 | |a Economics, Medical | |
| 650 | 2 | |a Health Policy |0 https://id.nlm.nih.gov/mesh/D006291 | |
| 650 | 6 | |a Économie de la santé. | |
| 650 | 6 | |a Politique sanitaire. | |
| 650 | 6 | |a Santé mondiale. | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Industries |x General. |2 bisacsh | |
| 650 | 7 | |a Medical economics |2 fast | |
| 650 | 7 | |a Medical policy |2 fast | |
| 650 | 7 | |a World health |2 fast | |
| 700 | 1 | |a Jakovljevic, Mihajlo, |e editor. | |
| 776 | 0 | 8 | |i Print version: |t Health economics and policy challenges in global emerging markets. |d Hauppauge, New York : Nova Publishers, [2016] |z 9781634847087 |w (DLC) 2016003445 |
| 830 | 0 | |a Public health in the 21st century series. |0 http://id.loc.gov/authorities/names/n2010180172 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBU |q FWS_PDA_EBU |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1226192 |3 Volltext |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL4586714 | ||
| 938 | |a EBSCOhost |b EBSC |n 1226192 | ||
| 938 | |a YBP Library Services |b YANK |n 12964768 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBU | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBU-ocn946277667 |
|---|---|
| _version_ | 1816796922383433728 |
| adam_text | |
| any_adam_object | |
| author2 | Jakovljevic, Mihajlo |
| author2_role | edt |
| author2_variant | m j mj |
| author_facet | Jakovljevic, Mihajlo |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RA410 |
| callnumber-raw | RA410.5 |
| callnumber-search | RA410.5 |
| callnumber-sort | RA 3410.5 |
| callnumber-subject | RA - Public Medicine |
| collection | ZDB-4-EBU |
| contents | HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 BRICS VS. N-11: POPULATION AGING AND HEALTH EXPENDITURES IN GLOBAL EMERGING MARKETS- HISTORICALS RECORDS AND UN FORECASTS 1975 -- 2025 ; ABSTRACT ; INTRODUCTION ; METHODS ; Data Sources; Data Analysis ; RESULTS ; DISCUSSION; STUDY LIMITATIONS ; CONCLUSION; ACKNOWLEDGMENTS ; REFERENCES. Chapter 2 WHAT CAN EMERGING MARKETS LEARN FROM A PUBLIC LONG-TERM CARE INSURANCE SYSTEM FROM A MATURE COUNTRY: EXPERIMENTAL STUDY? ABSTRACT ; INTRODUCTION ; METHODS; The Public Long-Term Care Insurance (LTCI) System in Japan ; Introduction of the LTCI System in Japan ; A Structural Model to Measure the Effect of Public Long-Term Care Insurance System on Welfare Changes in Households ; EMPIRICAL AND EXPERIMENTAL RESULTS AND ANALYSIS ; The Data Set ; The Robust OLS Results for the Pooled Cross Section Data Set ; The Robust OLS Results for the Two-Year Data Set (2000 and 2003) in Table 6. Calculation of Values of Risk, Loss Variance and Absolute Risk Aversion (ARA) Discussion about the Factor of Economic Recession ; SUMMARY AND CONCLUSION; REFERENCES ; Chapter 3 INCORPORATION OF MULTI-CRITERIA DECISION ANALYSIS INTO HEALTH TECHNOLOGY ASSESSMENT: EXPERIENCES AND CHALLENGES FROM BULGARIA ; ABSTRACT; INTRODUCTION ; METHODS ; Key Theoretical Issues of MCDA ; Selecting Criteria ; Generic and Case-Specific MCDA Models ; International Experience on Combining HTA and MCDA ; From a Single ICER Measure to a Broader Set of Criteria ; Practical Lessons from Real-World MCDA Models. Incorporation of MCDA into HTA in BulgariaThe Bulgarian Experience in Incorporating MCDA into HTA ; Weaknesses of the Bulgarian HTA Process ; Weaknesses of the Bulgarian MCDA Framework ; CONCLUSION ; REFERENCES ; Chapter 4 WILLINGNESS-TO-PAY FOR A NEW PHARMACEUTICAL: IS IT WORTH THE MONEY? WHOSE MONEY? ; ABSTRACT ; 1. INTRODUCTION ; 2. LITERATURE REVIEW ; Cost-Effectiveness Studies ; WTP Studies ; 3. THE EXPERIMENT ; Sample and Interview Strategy ; Questionnaire ; Attributes ; Pretest and Design ; 4. EX-ANTE VS. EX-POST WILLINGNESS TO PAY ; 5. HYPOTHESES ; 6. DATA: DESCRIPTIVE STATISTICS. 7. EMPIRICAL RESULTS7.1. Willingness-to-Pay Values ; 7.2. Willingness-to-Pay Values Across Subgroups ; CONCLUSION ; DISCLAIMER; REFERENCES ; Chapter 5 THE HEALTH ECONOMICS OF NON-EPILEPTIC ATTACK DISORDER IN IRELAND ; ABSTRACT ; INTRODUCTION ; Incidence and Prevalence of NEAD in Ireland ; Estimation of Costs; Cost-of-Illness Analysis ; Measurement of Costs ; Incidence of NEAD in Ireland ; Using Iceland Figures (Sigurdardottir and Olafsson, 1998) ; Using Hamilton County, Ohio, Figures (Szflarski et al. 2000) ; Economic Cost of NEAD in Ireland ; Prevalence Based Cost-of-Illness. |
| ctrlnum | (OCoLC)946277667 |
| dewey-full | 338.4/73621 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/73621 |
| dewey-search | 338.4/73621 |
| dewey-sort | 3338.4 573621 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05562cam a2200685 i 4500</leader><controlfield tag="001">ZDB-4-EBU-ocn946277667</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">160408s2016 nyu ob 001 0 eng </controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a"> 2016017031</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DLC</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">DLC</subfield><subfield code="d">N$T</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCF</subfield><subfield code="d">EBLCP</subfield><subfield code="d">YDX</subfield><subfield code="d">AGLDB</subfield><subfield code="d">AU@</subfield><subfield code="d">STF</subfield><subfield code="d">DLC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">959536277</subfield><subfield code="a">959650782</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781634847209</subfield><subfield code="q">(ebook)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1634847202</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781634847087</subfield><subfield code="q">(hardcover)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1634847083</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)946277667</subfield><subfield code="z">(OCoLC)959536277</subfield><subfield code="z">(OCoLC)959650782</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="050" ind1="1" ind2="0"><subfield code="a">RA410.5</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">W 74</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">BUS</subfield><subfield code="x">070000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">338.4/73621</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Health economics and policy challenges in global emerging markets /</subfield><subfield code="c">Mihajlo Jakovljevic, MD, PHD, editor.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York :</subfield><subfield code="b">Nova Publishers,</subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Public health in the 21st century</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record and CIP data provided by publisher.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 BRICS VS. N-11: POPULATION AGING AND HEALTH EXPENDITURES IN GLOBAL EMERGING MARKETS- HISTORICALS RECORDS AND UN FORECASTS 1975 -- 2025 ; ABSTRACT ; INTRODUCTION ; METHODS ; Data Sources; Data Analysis ; RESULTS ; DISCUSSION; STUDY LIMITATIONS ; CONCLUSION; ACKNOWLEDGMENTS ; REFERENCES.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Chapter 2 WHAT CAN EMERGING MARKETS LEARN FROM A PUBLIC LONG-TERM CARE INSURANCE SYSTEM FROM A MATURE COUNTRY: EXPERIMENTAL STUDY? ABSTRACT ; INTRODUCTION ; METHODS; The Public Long-Term Care Insurance (LTCI) System in Japan ; Introduction of the LTCI System in Japan ; A Structural Model to Measure the Effect of Public Long-Term Care Insurance System on Welfare Changes in Households ; EMPIRICAL AND EXPERIMENTAL RESULTS AND ANALYSIS ; The Data Set ; The Robust OLS Results for the Pooled Cross Section Data Set ; The Robust OLS Results for the Two-Year Data Set (2000 and 2003) in Table 6.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Calculation of Values of Risk, Loss Variance and Absolute Risk Aversion (ARA) Discussion about the Factor of Economic Recession ; SUMMARY AND CONCLUSION; REFERENCES ; Chapter 3 INCORPORATION OF MULTI-CRITERIA DECISION ANALYSIS INTO HEALTH TECHNOLOGY ASSESSMENT: EXPERIENCES AND CHALLENGES FROM BULGARIA ; ABSTRACT; INTRODUCTION ; METHODS ; Key Theoretical Issues of MCDA ; Selecting Criteria ; Generic and Case-Specific MCDA Models ; International Experience on Combining HTA and MCDA ; From a Single ICER Measure to a Broader Set of Criteria ; Practical Lessons from Real-World MCDA Models.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Incorporation of MCDA into HTA in BulgariaThe Bulgarian Experience in Incorporating MCDA into HTA ; Weaknesses of the Bulgarian HTA Process ; Weaknesses of the Bulgarian MCDA Framework ; CONCLUSION ; REFERENCES ; Chapter 4 WILLINGNESS-TO-PAY FOR A NEW PHARMACEUTICAL: IS IT WORTH THE MONEY? WHOSE MONEY? ; ABSTRACT ; 1. INTRODUCTION ; 2. LITERATURE REVIEW ; Cost-Effectiveness Studies ; WTP Studies ; 3. THE EXPERIMENT ; Sample and Interview Strategy ; Questionnaire ; Attributes ; Pretest and Design ; 4. EX-ANTE VS. EX-POST WILLINGNESS TO PAY ; 5. HYPOTHESES ; 6. DATA: DESCRIPTIVE STATISTICS.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">7. EMPIRICAL RESULTS7.1. Willingness-to-Pay Values ; 7.2. Willingness-to-Pay Values Across Subgroups ; CONCLUSION ; DISCLAIMER; REFERENCES ; Chapter 5 THE HEALTH ECONOMICS OF NON-EPILEPTIC ATTACK DISORDER IN IRELAND ; ABSTRACT ; INTRODUCTION ; Incidence and Prevalence of NEAD in Ireland ; Estimation of Costs; Cost-of-Illness Analysis ; Measurement of Costs ; Incidence of NEAD in Ireland ; Using Iceland Figures (Sigurdardottir and Olafsson, 1998) ; Using Hamilton County, Ohio, Figures (Szflarski et al. 2000) ; Economic Cost of NEAD in Ireland ; Prevalence Based Cost-of-Illness.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical economics.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85082915</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical policy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85083002</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">World health.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85148199</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Global Health</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014943</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Economics, Medical</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Health Policy</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D006291</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Économie de la santé.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Politique sanitaire.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Santé mondiale.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS</subfield><subfield code="x">Industries</subfield><subfield code="x">General.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medical economics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medical policy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">World health</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jakovljevic, Mihajlo,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Health economics and policy challenges in global emerging markets.</subfield><subfield code="d">Hauppauge, New York : Nova Publishers, [2016]</subfield><subfield code="z">9781634847087</subfield><subfield code="w">(DLC) 2016003445</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Public health in the 21st century series.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2010180172</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBU</subfield><subfield code="q">FWS_PDA_EBU</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1226192</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL4586714</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">1226192</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">12964768</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBU</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBU-ocn946277667 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-26T14:49:22Z |
| institution | BVB |
| isbn | 9781634847209 1634847202 |
| language | English |
| lccn | 2016017031 |
| oclc_num | 946277667 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource |
| psigel | ZDB-4-EBU |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | Nova Publishers, |
| record_format | marc |
| series | Public health in the 21st century series. |
| series2 | Public health in the 21st century |
| spelling | Health economics and policy challenges in global emerging markets / Mihajlo Jakovljevic, MD, PHD, editor. New York : Nova Publishers, [2016] 1 online resource text txt rdacontent computer c rdamedia online resource cr rdacarrier Public health in the 21st century Includes bibliographical references and index. Print version record and CIP data provided by publisher. HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 BRICS VS. N-11: POPULATION AGING AND HEALTH EXPENDITURES IN GLOBAL EMERGING MARKETS- HISTORICALS RECORDS AND UN FORECASTS 1975 -- 2025 ; ABSTRACT ; INTRODUCTION ; METHODS ; Data Sources; Data Analysis ; RESULTS ; DISCUSSION; STUDY LIMITATIONS ; CONCLUSION; ACKNOWLEDGMENTS ; REFERENCES. Chapter 2 WHAT CAN EMERGING MARKETS LEARN FROM A PUBLIC LONG-TERM CARE INSURANCE SYSTEM FROM A MATURE COUNTRY: EXPERIMENTAL STUDY? ABSTRACT ; INTRODUCTION ; METHODS; The Public Long-Term Care Insurance (LTCI) System in Japan ; Introduction of the LTCI System in Japan ; A Structural Model to Measure the Effect of Public Long-Term Care Insurance System on Welfare Changes in Households ; EMPIRICAL AND EXPERIMENTAL RESULTS AND ANALYSIS ; The Data Set ; The Robust OLS Results for the Pooled Cross Section Data Set ; The Robust OLS Results for the Two-Year Data Set (2000 and 2003) in Table 6. Calculation of Values of Risk, Loss Variance and Absolute Risk Aversion (ARA) Discussion about the Factor of Economic Recession ; SUMMARY AND CONCLUSION; REFERENCES ; Chapter 3 INCORPORATION OF MULTI-CRITERIA DECISION ANALYSIS INTO HEALTH TECHNOLOGY ASSESSMENT: EXPERIENCES AND CHALLENGES FROM BULGARIA ; ABSTRACT; INTRODUCTION ; METHODS ; Key Theoretical Issues of MCDA ; Selecting Criteria ; Generic and Case-Specific MCDA Models ; International Experience on Combining HTA and MCDA ; From a Single ICER Measure to a Broader Set of Criteria ; Practical Lessons from Real-World MCDA Models. Incorporation of MCDA into HTA in BulgariaThe Bulgarian Experience in Incorporating MCDA into HTA ; Weaknesses of the Bulgarian HTA Process ; Weaknesses of the Bulgarian MCDA Framework ; CONCLUSION ; REFERENCES ; Chapter 4 WILLINGNESS-TO-PAY FOR A NEW PHARMACEUTICAL: IS IT WORTH THE MONEY? WHOSE MONEY? ; ABSTRACT ; 1. INTRODUCTION ; 2. LITERATURE REVIEW ; Cost-Effectiveness Studies ; WTP Studies ; 3. THE EXPERIMENT ; Sample and Interview Strategy ; Questionnaire ; Attributes ; Pretest and Design ; 4. EX-ANTE VS. EX-POST WILLINGNESS TO PAY ; 5. HYPOTHESES ; 6. DATA: DESCRIPTIVE STATISTICS. 7. EMPIRICAL RESULTS7.1. Willingness-to-Pay Values ; 7.2. Willingness-to-Pay Values Across Subgroups ; CONCLUSION ; DISCLAIMER; REFERENCES ; Chapter 5 THE HEALTH ECONOMICS OF NON-EPILEPTIC ATTACK DISORDER IN IRELAND ; ABSTRACT ; INTRODUCTION ; Incidence and Prevalence of NEAD in Ireland ; Estimation of Costs; Cost-of-Illness Analysis ; Measurement of Costs ; Incidence of NEAD in Ireland ; Using Iceland Figures (Sigurdardottir and Olafsson, 1998) ; Using Hamilton County, Ohio, Figures (Szflarski et al. 2000) ; Economic Cost of NEAD in Ireland ; Prevalence Based Cost-of-Illness. Medical economics. http://id.loc.gov/authorities/subjects/sh85082915 Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 World health. http://id.loc.gov/authorities/subjects/sh85148199 Global Health https://id.nlm.nih.gov/mesh/D014943 Economics, Medical Health Policy https://id.nlm.nih.gov/mesh/D006291 Économie de la santé. Politique sanitaire. Santé mondiale. BUSINESS & ECONOMICS Industries General. bisacsh Medical economics fast Medical policy fast World health fast Jakovljevic, Mihajlo, editor. Print version: Health economics and policy challenges in global emerging markets. Hauppauge, New York : Nova Publishers, [2016] 9781634847087 (DLC) 2016003445 Public health in the 21st century series. http://id.loc.gov/authorities/names/n2010180172 FWS01 ZDB-4-EBU FWS_PDA_EBU https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1226192 Volltext |
| spellingShingle | Health economics and policy challenges in global emerging markets / Public health in the 21st century series. HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; HEALTH ECONOMICS AND POLICY CHALLENGES IN GLOBAL EMERGING MARKETS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 BRICS VS. N-11: POPULATION AGING AND HEALTH EXPENDITURES IN GLOBAL EMERGING MARKETS- HISTORICALS RECORDS AND UN FORECASTS 1975 -- 2025 ; ABSTRACT ; INTRODUCTION ; METHODS ; Data Sources; Data Analysis ; RESULTS ; DISCUSSION; STUDY LIMITATIONS ; CONCLUSION; ACKNOWLEDGMENTS ; REFERENCES. Chapter 2 WHAT CAN EMERGING MARKETS LEARN FROM A PUBLIC LONG-TERM CARE INSURANCE SYSTEM FROM A MATURE COUNTRY: EXPERIMENTAL STUDY? ABSTRACT ; INTRODUCTION ; METHODS; The Public Long-Term Care Insurance (LTCI) System in Japan ; Introduction of the LTCI System in Japan ; A Structural Model to Measure the Effect of Public Long-Term Care Insurance System on Welfare Changes in Households ; EMPIRICAL AND EXPERIMENTAL RESULTS AND ANALYSIS ; The Data Set ; The Robust OLS Results for the Pooled Cross Section Data Set ; The Robust OLS Results for the Two-Year Data Set (2000 and 2003) in Table 6. Calculation of Values of Risk, Loss Variance and Absolute Risk Aversion (ARA) Discussion about the Factor of Economic Recession ; SUMMARY AND CONCLUSION; REFERENCES ; Chapter 3 INCORPORATION OF MULTI-CRITERIA DECISION ANALYSIS INTO HEALTH TECHNOLOGY ASSESSMENT: EXPERIENCES AND CHALLENGES FROM BULGARIA ; ABSTRACT; INTRODUCTION ; METHODS ; Key Theoretical Issues of MCDA ; Selecting Criteria ; Generic and Case-Specific MCDA Models ; International Experience on Combining HTA and MCDA ; From a Single ICER Measure to a Broader Set of Criteria ; Practical Lessons from Real-World MCDA Models. Incorporation of MCDA into HTA in BulgariaThe Bulgarian Experience in Incorporating MCDA into HTA ; Weaknesses of the Bulgarian HTA Process ; Weaknesses of the Bulgarian MCDA Framework ; CONCLUSION ; REFERENCES ; Chapter 4 WILLINGNESS-TO-PAY FOR A NEW PHARMACEUTICAL: IS IT WORTH THE MONEY? WHOSE MONEY? ; ABSTRACT ; 1. INTRODUCTION ; 2. LITERATURE REVIEW ; Cost-Effectiveness Studies ; WTP Studies ; 3. THE EXPERIMENT ; Sample and Interview Strategy ; Questionnaire ; Attributes ; Pretest and Design ; 4. EX-ANTE VS. EX-POST WILLINGNESS TO PAY ; 5. HYPOTHESES ; 6. DATA: DESCRIPTIVE STATISTICS. 7. EMPIRICAL RESULTS7.1. Willingness-to-Pay Values ; 7.2. Willingness-to-Pay Values Across Subgroups ; CONCLUSION ; DISCLAIMER; REFERENCES ; Chapter 5 THE HEALTH ECONOMICS OF NON-EPILEPTIC ATTACK DISORDER IN IRELAND ; ABSTRACT ; INTRODUCTION ; Incidence and Prevalence of NEAD in Ireland ; Estimation of Costs; Cost-of-Illness Analysis ; Measurement of Costs ; Incidence of NEAD in Ireland ; Using Iceland Figures (Sigurdardottir and Olafsson, 1998) ; Using Hamilton County, Ohio, Figures (Szflarski et al. 2000) ; Economic Cost of NEAD in Ireland ; Prevalence Based Cost-of-Illness. Medical economics. http://id.loc.gov/authorities/subjects/sh85082915 Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 World health. http://id.loc.gov/authorities/subjects/sh85148199 Global Health https://id.nlm.nih.gov/mesh/D014943 Economics, Medical Health Policy https://id.nlm.nih.gov/mesh/D006291 Économie de la santé. Politique sanitaire. Santé mondiale. BUSINESS & ECONOMICS Industries General. bisacsh Medical economics fast Medical policy fast World health fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85082915 http://id.loc.gov/authorities/subjects/sh85083002 http://id.loc.gov/authorities/subjects/sh85148199 https://id.nlm.nih.gov/mesh/D014943 https://id.nlm.nih.gov/mesh/D006291 |
| title | Health economics and policy challenges in global emerging markets / |
| title_auth | Health economics and policy challenges in global emerging markets / |
| title_exact_search | Health economics and policy challenges in global emerging markets / |
| title_full | Health economics and policy challenges in global emerging markets / Mihajlo Jakovljevic, MD, PHD, editor. |
| title_fullStr | Health economics and policy challenges in global emerging markets / Mihajlo Jakovljevic, MD, PHD, editor. |
| title_full_unstemmed | Health economics and policy challenges in global emerging markets / Mihajlo Jakovljevic, MD, PHD, editor. |
| title_short | Health economics and policy challenges in global emerging markets / |
| title_sort | health economics and policy challenges in global emerging markets |
| topic | Medical economics. http://id.loc.gov/authorities/subjects/sh85082915 Medical policy. http://id.loc.gov/authorities/subjects/sh85083002 World health. http://id.loc.gov/authorities/subjects/sh85148199 Global Health https://id.nlm.nih.gov/mesh/D014943 Economics, Medical Health Policy https://id.nlm.nih.gov/mesh/D006291 Économie de la santé. Politique sanitaire. Santé mondiale. BUSINESS & ECONOMICS Industries General. bisacsh Medical economics fast Medical policy fast World health fast |
| topic_facet | Medical economics. Medical policy. World health. Global Health Economics, Medical Health Policy Économie de la santé. Politique sanitaire. Santé mondiale. BUSINESS & ECONOMICS Industries General. Medical economics Medical policy World health |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1226192 |
| work_keys_str_mv | AT jakovljevicmihajlo healtheconomicsandpolicychallengesinglobalemergingmarkets |